BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9868307)

  • 1. [A case of Satoyoshi syndrome with symptoms resembling neuroleptic malignant syndrome].
    Adachi H; Riku S; Fujishiro K; Kuru S
    Rinsho Shinkeigaku; 1998 Jul; 38(7):637-40. PubMed ID: 9868307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of "syndrome of progressive muscle spasm, alopecia, and diarrhea (Satoyoshi)" treated with steroid pulse therapy].
    Kuru S; Riku S; Nakayabu M; Kobayashi Y; Ieda T
    Rinsho Shinkeigaku; 1992 Jun; 32(6):612-5. PubMed ID: 1424340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of generalized komuragaeri disease (Satoyoshi disease) treated with glucocorticoid].
    Yamagata T; Miyao M; Momoi M; Matsumoto S; Yanagisawa M
    Rinsho Shinkeigaku; 1991 Jan; 31(1):79-83. PubMed ID: 2044311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
    Wait SD; Ponce FA; Killory BD; Wallace D; Rekate HL
    J Neurosurg Pediatr; 2009 Sep; 4(3):217-21. PubMed ID: 19772404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
    Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
    Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
    Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
    Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
    Seki Y; Takahashi H; Aizawa Y
    Rinsho Ketsueki; 1998 May; 39(5):374-8. PubMed ID: 9637888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The malignant neuroleptic syndrome and malignant hyperthermia].
    Mitterschiffthaler G; Hackl JM; Neumann R
    Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of neuroleptic malignant syndrome developed in liver cirrhosis patient addicted to alcohol].
    Minamisawa S; Tezuka T; Enomoto K; Nozaki Y; Funatomi H; Hatta Y
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):367-72. PubMed ID: 1772376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome among acute psychiatric admissions in Barbados.
    Mansoor GA; Corbin DO; Edwards CN; Nicholson GD; Asokan G; Bannister P
    West Indian Med J; 1992 Mar; 41(1):15-8. PubMed ID: 1566588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satoyoshi syndrome: an unusual postnatal multisystemic disorder.
    Ehlayel MS; Lacassie Y
    Am J Med Genet; 1995 Jul; 57(4):620-5. PubMed ID: 7573141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
    Lazzarin M; Benati F; Cesario V
    Recenti Prog Med; 1996 Sep; 87(9):422-4. PubMed ID: 9053957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The neuroleptic malignant syndrome].
    Dammers S; Zeit T; Leonhardt M; Schär V; Agelink MW
    Dtsch Med Wochenschr; 1995 Dec; 120(50):1739-42. PubMed ID: 8542810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome in a patient with polyneuropathy: mechanism of muscle rigidity and elevated serum creatine kinase levels].
    Takashima S; Hirade S; Taguchi Y; Inoue H
    Rinsho Shinkeigaku; 1998; 38(10-11):955-7. PubMed ID: 10203983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G; Rónai L
    Orv Hetil; 1995 Oct; 136(40):2173-6. PubMed ID: 7566952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.